McKesson Corporation (NYSE:MCK) Receives $960.93 Average Price Target from Analysts

Shares of McKesson Corporation (NYSE:MCK) have received an average recommendation of “Moderate Buy” from the seventeen analysts that are covering the firm, Marketbeat.com reports. Four equities research analysts have rated the stock with a hold recommendation and thirteen have given a buy recommendation to the company. The average 1 year price objective among brokers that have issued ratings on the stock in the last year is $960.9333.

A number of analysts have recently weighed in on the company. Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating on shares of McKesson in a research report on Wednesday, December 10th. JPMorgan Chase & Co. boosted their target price on McKesson from $983.00 to $1,107.00 and gave the stock an “overweight” rating in a research note on Tuesday, February 10th. Weiss Ratings downgraded McKesson from a “buy (a-)” rating to a “buy (b+)” rating in a report on Thursday, February 5th. Raymond James Financial set a $970.00 price target on McKesson in a research report on Thursday, March 5th. Finally, Morgan Stanley reiterated an “overweight” rating and issued a $966.00 price objective on shares of McKesson in a research note on Thursday, January 29th.

McKesson Stock Performance

NYSE MCK opened at $864.43 on Friday. The firm has a market cap of $105.88 billion, a price-to-earnings ratio of 24.86, a PEG ratio of 1.42 and a beta of 0.38. The firm has a 50 day simple moving average of $907.21 and a 200-day simple moving average of $837.67. McKesson has a one year low of $637.00 and a one year high of $999.00.

McKesson (NYSE:MCK) last announced its earnings results on Wednesday, February 4th. The company reported $9.34 earnings per share for the quarter, topping the consensus estimate of $9.19 by $0.15. The firm had revenue of $106.16 billion for the quarter, compared to the consensus estimate of $105.98 billion. McKesson had a net margin of 1.09% and a negative return on equity of 338.97%. The firm’s revenue for the quarter was up 11.4% on a year-over-year basis. During the same period in the prior year, the firm earned $8.03 EPS. McKesson has set its FY 2026 guidance at 38.800-39.200 EPS. Equities analysts predict that McKesson will post 32.77 EPS for the current fiscal year.

McKesson Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Wednesday, April 1st. Investors of record on Monday, March 2nd will be paid a $0.82 dividend. The ex-dividend date is Monday, March 2nd. This represents a $3.28 dividend on an annualized basis and a yield of 0.4%. McKesson’s payout ratio is currently 9.43%.

Insider Buying and Selling

In other McKesson news, EVP Michele Lau sold 2,725 shares of the business’s stock in a transaction that occurred on Monday, March 2nd. The shares were sold at an average price of $990.00, for a total transaction of $2,697,750.00. Following the completion of the transaction, the executive vice president owned 3,247 shares in the company, valued at $3,214,530. The trade was a 45.63% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, CAO Napoleon B. Rutledge, Jr. sold 328 shares of the stock in a transaction that occurred on Friday, February 6th. The shares were sold at an average price of $955.00, for a total transaction of $313,240.00. The SEC filing for this sale provides additional information. Insiders have sold 3,868 shares of company stock valued at $3,743,820 over the last ninety days. 0.08% of the stock is currently owned by corporate insiders.

Institutional Trading of McKesson

A number of hedge funds and other institutional investors have recently bought and sold shares of MCK. GGM Financials LLC acquired a new stake in shares of McKesson during the 3rd quarter worth about $25,000. University of Texas Texas AM Investment Management Co. acquired a new position in McKesson in the fourth quarter valued at approximately $25,000. Swiss RE Ltd. acquired a new position in McKesson in the fourth quarter valued at approximately $26,000. State of Wyoming purchased a new position in McKesson in the second quarter valued at approximately $29,000. Finally, Hopwood Financial Services Inc. purchased a new position in McKesson in the third quarter valued at approximately $31,000. 85.07% of the stock is currently owned by institutional investors and hedge funds.

McKesson Company Profile

McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.